Yonhap Infomax NewsFeb 11, 2025
Vertex Pharmaceuticals stock rebounds as Q4 earnings exceed expectations and 2025 revenue guidance surpasses market forecasts, despite slight EPS miss
#YonhapInfomax #VertexPharmaceuticals #Q4Earnings #RevenueGuidance #FDAApproval #Journavax #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=50349
Vertex Pharmaceuticals Stock Rebounds on Better-Than-Expected Earnings and Guidance

Vertex Pharmaceuticals stock rebounds as Q4 earnings exceed expectations and 2025 revenue guidance surpasses market forecasts, despite slight EPS miss

Yonhap Infomax